2004/169/EC: Commission Decision of 26 November 2003 on the aid which Italy is planning to implement for Industria Farmaceutica Cesare Serono SpA for the development of new chemical synthesis processes for oral pharmaceutical forms of polypeptides and conjugated substances (notified under document number C(2003) 3519) (Text with EEA relevance)

• Articles: 2

Article 1

The preclinical testing "step" of the project notified by the Republic of Italy for the development of new chemical synthesis processes for oral pharmaceutical forms of polypeptides and conjugated substances constitutes industrial research within the meaning of the Community framework for State aid for research and development and may, therefore, be funded to the extent of 50 % gross grant equivalent.

The aid not exceeding this intensity is, therefore, compatible with the common market pursuant to Article 87(3)(c) of the EC Treaty.

Article 2

This Decision is addressed to the Republic of Italy.

Done at Brussels, 26 November 2003.

For the Commission

Mario Monti

Member of the Commission

(1) OJ L 83, 27.3.1999, p. 1.

(2) OJ C 110, 8.5.2003, p. 2.

(3) And its implementing regulation: Ministerial Decree No 593 of 8 August 2000.

(4) OJ C 310, 28.10.2000, p. 17.

(5) OJ L 10, 13.1.2001, p. 20.

(6) OJ C 45, 17.2.1996, p. 6.